Gradient Investments LLC Vertex Pharmaceuticals Inc Transaction History

Gradient Investments LLC

$3.79 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$407.69 - $446.08 $47,292 - $51,745	-116 Reduced 75.32%	38 $15,000
Q4 2023 Jan 18, 2024	SELL	$343.0 - $410.68 $8,575 - $10,267	-25 Reduced 13.97%	154 $62,000
Q3 2023 Oct 27, 2023	BUY	$338.18 - $362.46 $53,094 - $56,906	157 Added 713.64%	179 $62,000
Q2 2023 Jul 11, 2023	BUY	$314.42 - $351.91 $3,144 - $3,519	10 Added 83.33%	22 $7,000
Q1 2023 Apr 17, 2023	BUY	$283.23 - $323.1 $1,416 - $1,615	5 Added 71.43%	12 $3,000
Q4 2022 Jan 10, 2023	BUY	$285.76 - $321.48 $2,000 - $2,250	7 New	7 $0
Q4 2021 Jan 12, 2022	SELL	$177.01 - $223.45 $531 - $670	-3 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$181.39 - $202.99 $3,265 - $3,653	-18 Reduced 85.71%	3 $1,000
Q2 2021 Jul 12, 2021	SELL	$187.49 - $221.1 $937 - $1,105	-5 Reduced 19.23%	21 $4,000
Q1 2021 Apr 21, 2021	SELL	$207.02 - $241.31 $686,271 - $799,942	-3,315 Reduced 99.22%	26 $6,000
Q4 2020 Jan 08, 2021	SELL	$207.01 - $276.09 $23,392 - $31,198	-113 Reduced 3.27%	3,341 $909,000
Q3 2020 Oct 06, 2020	SELL	$255.65 - $303.1 $791,492 - $938,397	-3,096 Reduced 47.27%	3,454 $940,000
Q2 2020 Jul 10, 2020	SELL	$225.48 - $295.8 $222,999 - $292,546	-989 Reduced 13.12%	6,550 $1.9 Million
Q1 2020 Apr 07, 2020	BUY	$199.77 - $247.81 $178,394 - $221,294	893 Added 13.44%	7,539 $1.79 Million
Q4 2019 Jan 15, 2020	SELL	$166.71 - $223.91 $44,178 - $59,336	-265 Reduced 3.83%	6,646 $1.46 Million
Q3 2019 Oct 10, 2019	BUY	$166.23 - $187.09 $138,802 - $156,220	835 Added 13.74%	6,911 $1.17 Million
Q2 2019 Jul 16, 2019	BUY	$164.61 - $190.37 $1 Million - $1.16 Million	6,076 New	6,076 $1.11 Million
Q1 2018 Apr 11, 2018	SELL	$151.6 - $177.13 $1,970 - $2,302	-13 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$137.28 - $155.55 $1,784 - $2,022	13	13 $2,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account